Literature DB >> 20834028

C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence?

Stavroula N Psychari1, Dionyssios Chatzopoulos, Efstathios K Iliodromitis, Thomas S Apostolou, Dimitrios T Kremastinos.   

Abstract

AIMS: We investigated the role of high-sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), and N-terminal pro-brain natriuretic peptide (NTpro-BNP), in atrial fibrillation (AF) recurrence rate.
METHODS: A total of 80 patients with first AF episode were studied prospectively. Echocardiography (ECG), Holter ECG, and measurements of hsCRP, IL-6, and NTproBNP were performed immediately post conversion and at 1 month.
RESULTS: Recurrence was positively related to left atrial volume (P < .001), with no difference in NTpro-BNP, hsCRP, and IL-6. Decreased NTpro-BNP was observed in all at 1 month (P < .001, F = 63.4) and was positively related to left atrial volume (P < .01). In the lone AF subgroup, NTpro-BNP was lower and dropped significantly at 1 month (interaction F = 6.53, P < .01).
CONCLUSIONS: Atrial volume was related to AF recurrence, whereas hsCRP, IL-6, and NTpro-BNP were not reliable for AF relapse. Relation of NTpro-BNP to left atrial volume could indicate a role in the atrial remodeling process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20834028     DOI: 10.1177/0003319710382418

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.

Authors:  Jinqi Fan; Hua Cao; Li Su; Zhiyu Ling; Zengzhang Liu; Xianbin Lan; Yanping Xu; Weijie Chen; Yuehui Yin
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

Review 2.  [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].

Authors:  Jelena Kornej; Katja Schumacher; Daniela Husser; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14

3.  Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.

Authors:  Rupak Mukherjee; Joseph G Akar; J Marcus Wharton; Deborah K Adams; Catherine D McClure; Robert E Stroud; Allison D Rice; Stacia M DeSantis; Francis G Spinale; Michael R Gold
Journal:  J Cardiovasc Transl Res       Date:  2013-05-31       Impact factor: 4.132

Review 4.  Value of high-sensitivity C-reactive protein assays in predicting atrial fibrillation recurrence: a systematic review and meta-analysis.

Authors:  Chia-Hung Yo; Si-Huei Lee; Shy-Shin Chang; Matthew Chien-Hung Lee; Chien-Chang Lee
Journal:  BMJ Open       Date:  2014-02-20       Impact factor: 2.692

Review 5.  Almanac 2015: atrial fibrillation research in Heart.

Authors:  Muhammad Jawad-Ul-Qamar; Paulus Kirchhof
Journal:  Heart       Date:  2016-01-20       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.